Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves
Top Cited Papers
Open Access
- 18 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (4), 1027-1038
- https://doi.org/10.1093/jac/dkr570
Abstract
To document and quantify drug use in white veal calves, an intensive livestock production system where multidrug resistance is abundantly present. Drug consumption data were prospectively collected on 15 white veal production cohorts (n = 5853 calves) in Belgium (2007–09). Treatment incidences (TIs) based on animal defined daily dose (ADD), prescribed daily dose (PDD) and used daily dose (UDD) were calculated. Risk factors were identified by linear regression. The average TIADD of antimicrobial treatments was 416.8 ADD per 1000 animals at risk. Predominantly, oral group antimicrobial treatments were used (95.8%). Of the oral group antimicrobial treatments, 12% and 88% were used for prophylactic or metaphylactic indications, respectively. The main indication for group and individual drug use was respiratory disease. The most frequently used antimicrobials (group treatments) were oxytetracycline (23.7%), amoxicillin (18.5%), tylosin (17.2%) and colistin (15.2%). Deviations from the leaflet dosage recommendations were frequently encountered, with 43.7% of the group treatments underdosed (often oxytetracycline and tylosin to treat dysbacteriosis). In 33.3% of the oral antimicrobial group treatments a combination of two antimicrobial preparations was used. Smaller integrations used more antimicrobials in group treatments than larger ones (P < 0.05); an integration is defined as a company that combines all steps of the production chain by having its own feed plant and slaughterhouse and by placing its calves in veal herds owned by producers that fatten these calves for this integration on contract. Producers used higher dosages than prescribed by the veterinarian in cohorts with a single caretaker (P < 0.01). The present study provided detailed information on the intensive antimicrobial use in the white veal industry. Reduction can only be achieved by reducing the number of oral group treatments.This publication has 41 references indexed in Scilit:
- Prevalence of respiratory pathogens in diseased, non‐vaccinated, routinely medicated veal calvesVeterinary Record, 2011
- Demonstration of the metaphylactic use of gamithromycin against bacterial pathogens associated with bovine respiratory disease in a multicentre farm trialVeterinary Record, 2011
- Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007Journal of Antimicrobial Chemotherapy, 2010
- Methicillin Resistant Staphylococcus aureus ST398 in Veal Calf Farming: Human MRSA Carriage Related with Animal Antimicrobial Usage and Farm HygienePLOS ONE, 2010
- Methicillin-resistantStaphylococcus aureus(MRSA) in food production animalsEpidemiology and Infection, 2010
- Efficacy of metaphylactic florfenicol therapy during natural outbreaks of bovine respiratory diseaseJournal of Veterinary Pharmacology and Therapeutics, 2008
- Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002–2004Acta Veterinaria Scandinavica, 2008
- Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002 – 2004: the ARBAO-II studyActa Veterinaria Scandinavica, 2008
- Molecular Epidemiology of Ceftiofur-Resistant Escherichia coli Isolates from Dairy CalvesApplied and Environmental Microbiology, 2006
- Field Trial Evaluating the Influence of Prophylactic and Therapeutic Antimicrobial Administration on Antimicrobial Resistance of Fecal Escherichia coli in Dairy CalvesApplied and Environmental Microbiology, 2006